Manchester Capital Management’s Pediatrix Medical MD Stock Holding History

Manchester Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.29K	Buy	107 +14	+15%	+$291	﹤0.01%	993
2025 Q4	$1.99K	Hold	93	–	–	﹤0.01%	1022
2025 Q3	$1.56K	Sell	93 -19	-17%	-$285	﹤0.01%	1106
2025 Q2	$1.61K	Buy	112 +19	+20%	+$261	﹤0.01%	1022
2025 Q1	$1.35K	Hold	93	–	–	﹤0.01%	1029
2024 Q4	$1.22K	Hold	93	–	–	﹤0.01%	1029
2024 Q3	$1.08K	Hold	93	–	–	﹤0.01%	1032
2024 Q2	$703	Buy	93 +68	+272%	+$563	﹤0.01%	1038
2024 Q1	$251	Buy	25 +11	+79%	+$102	﹤0.01%	989
2023 Q4	$131	Buy	14 +4	+40%	+$41	﹤0.01%	987
2023 Q3	$128	Buy	+10	New	+$137	﹤0.01%	982
2023 Q2	–	Sell	-51	Closed	-$761	–	1074
2023 Q1	$761	Hold	51	–	–	﹤0.01%	955
2022 Q4	$758	Buy	51 +29	+132%	+$473	﹤0.01%	859
2022 Q3	$0	Sell	22 -9	-29%	-$181	﹤0.01%	958
2022 Q2	$1K	Sell	31 -1	-3%	-$20	﹤0.01%	846
2022 Q1	$1K	Hold	32	–	–	﹤0.01%	952
2021 Q4	$1K	Sell	32 -112	-78%	-$3K	﹤0.01%	951
2021 Q3	$4K	Buy	+144	New	+$4.39K	﹤0.01%	735

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Manchester Capital Management's MD Position: Q1 2026 in Review

Manchester Capital Management increased its Pediatrix Medical (MD) stake by 15% in Q1 2026, buying an estimated $291 and bringing the position to 107 shares worth $2.29K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Manchester Capital Management first reported a position in MD in Q3 2021 and has held it in 18 quarters since. The position peaked at $4K in Q3 2021. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

Manchester Capital Management held 107 shares of Pediatrix Medical worth $2.29K as of Q1 2026.
Manchester Capital Management bought 14 Pediatrix Medical shares in Q1 2026, an estimated $291.
Pediatrix Medical made up ﹤0.01% of Manchester Capital Management's portfolio in Q1 2026, its #993 holding.
Manchester Capital Management first reported a position in Pediatrix Medical in Q3 2021 and has held it in 18 quarters since.
Manchester Capital Management's Pediatrix Medical position peaked at $4K in Q3 2021.
296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.